PYPD

Polypid Ltd.

• Reuters·2d ago

  PolyPid starts trading on Frankfurt Stock Exchange under 2PV, adding to Nasdaq listing

• Reuters·4d ago

  PolyPid director Yitzhak Jacobovitz files initial beneficial ownership statement

• Reuters·4d ago

  PolyPid files Form 3 disclosing director Robert Benjamin Stein holdings

• Reuters·03/31 21:31

  PolyPid initiates rolling FDA NDA submission for D-PLEX100 in colorectal surgery SSIs

• TipRanks·03/31 18:16

  PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections

• TipRanks·03/31 14:30

  PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)

• Reuters·03/31 12:43

  BRIEF-Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA

• Reuters·03/26 20:01

  PolyPid files initial beneficial ownership statement; COO-US Ori Warshavsky reports 267 ordinary shares owned directly

• Reuters·03/26 12:56

  PolyPid files initial beneficial ownership statement; director Nir Dror-Darwish reports 14,440 stock options at $2.67

• Reuters·03/23 20:01

  PolyPid Ltd. CFO Jonathan Missulawin files initial beneficial ownership statement

• Reuters·03/23 12:04

  PolyPid Director Joseph BenAmram Files Initial Beneficial Ownership Statement

• TipRanks·03/18 20:40

  Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Axsome Therapeutics (AXSM)

• Reuters·03/18 20:05

  PolyPid Director Brooke Story Files Initial Beneficial Ownership Statement

• Reuters·03/18 20:04

  PolyPid CEO and Director Dikla Czaczkes Akselbrad Files Initial Beneficial Ownership Statement

• Reuters·03/18 20:03

  PolyPid Deputy CEO Dalit Fellous Hazan Files Initial Beneficial Ownership Statement